Tenet Healthcare (THC) Cost of Revenue (2009 - 2026)

Tenet Healthcare (THC) has 18 years of Cost of Revenue data on file, last reported at $961.0 million in Q1 2026.

• Quarterly Cost of Revenue fell 11.83% year-over-year to $961.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 billion (down 13.58% YoY) and the FY2025 annual result came in at $3.8 billion, down 15.85% from the prior year.
• Cost of Revenue fell to $961.0 million in Q1 2026 per THC's latest filing, from $1.0 billion in the prior quarter.
• The five-year high for Cost of Revenue was $1.8 billion in Q4 2024, with the low at $811.0 million in Q2 2022.
• Average Cost of Revenue over 5 years is $1.0 billion, with a median of $942.0 million recorded in 2022.
• Year-over-year, Cost of Revenue soared 90.66% in 2024 and slumped 43.1% in 2025.
• Tenet Healthcare's Cost of Revenue stood at $1.0 billion in 2022, then decreased by 9.79% to $931.0 million in 2023, then soared by 90.66% to $1.8 billion in 2024, then tumbled by 43.1% to $1.0 billion in 2025, then decreased by 4.85% to $961.0 million in 2026.
• Business Quant data shows THC's Cost of Revenue at $961.0 million in Q1 2026, $1.0 billion in Q4 2025, and $1.1 billion in Q3 2025.